Study explains why cancer immunity declines faster in males
Lutz Menzel, PhD, formerly of the Department of Radiation Oncology within the Mass General Brigham Cancer Institute, and…
New BCR analysis method tracks immune recovery after stem cell transplantation
A research team led by Associate Professor Yohei Funakoshi, Associate Professor Kimikazu Yakushijin, and Professor Hironobu Minami of…
Baseline liver fibrosis severity predicts treatment response in patients with HBeAg-positive CHB
Background and aims The impact of baseline liver fibrosis severity on the effectiveness of pegylated interferon (Peg-IFN) combined…
City of Hope develops adaptive plug-and-play CAR T technology to attack tumors
Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in…
Could scorpion venom inspire new treatments for liver disease?
From blocking inflammatory immune pathways to disrupting hepatitis viruses, scorpion-derived peptides are attracting attention as potential drug candidates,…
Scientists traced a hidden immune route that may worsen tau-linked brain damage
Researchers traced an immune pathway from brain-draining lymph nodes to tau-affected tissue, revealing how peripheral immune activity may…
Whanganui GP appointments, prescriptions, RAT sales swell as late flu surge enters spring
An intermediate school student she treated had influenza A for nine days, she said. Healthcare staff and their…
Optimal prostate-specific antigen cutoff linked to improved prostate cancer survival
After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an…
Integrated nanomaterials offer new strategies for cancer immunotherapy
Immune checkpoint inhibitors, cancer vaccines and cellular therapies have reshaped oncology, yet most patients still do not achieve…
Wistar scientists develop new bispecific T cell engager to target ovarian cancer
Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against…
Bifidobacterium-based oral vaccine enhances anti-tumor immunity in clinical study
A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity. In an exploratory phase I…
Memory B cells reveal how nasal vaccines could stop respiratory infections earlier
New insights into lung-resident memory B cells show why the next generation of vaccines may need to protect…